Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

67.69
Delayed Data
As of Jul 31
 +0.50 / +0.74%
Today’s Change
35.38
Today|||52-Week Range
72.51
+50.86%
Year-to-Date

Today’s Trading

Previous close67.19
Today’s open67.34
Day’s range66.82 - 69.29
Volume219,342
Average volume (3 months)340,703
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+53.47%
Earnings growth (this year)+4.02%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales36.17
Price/Book15.64

Competitors

 Today’s
change
Today’s
% change
HALOHalozyme Therapeutic...+0.21+0.91%
ATRAAtara Biotherapeutic...+0.52+0.93%
IMGNImmunoGen Inc+0.12+0.67%
KITEKite Pharma Inc+1.47+2.06%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.95
Annual revenue (last year)$41.3M
Annual profit (last year)-$98.2M
Net profit margin-237.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
Vice Chairman &
President
Samir Chandrakant Patel
Corporate headquarters
New York, New York

Forecasts